Anduril In Talks For Employee Sale At $90B Valuation logo

Anduril In Talks For Employee Sale At $90B Valuation

The Information reports Anduril is discussing an employee share sale valuing the defense-tech company at $90 billion, a separate track from reported talks on a new primary round near $100 billion.

By the Numbers

$90B (reported)
Employee sale valuation
~$100B (reported)
Primary round talks
$5B/$61B (reported)
Series H, May 2026
Thrive, a16z
Series H lead investors
ShareXLinkedInEmail

THE RUNDOWN

1

An employee tender at $90 billion would give Anduril staff a liquidity event without the company raising new primary capital or diluting existing holders.

2

It lands below the roughly $100 billion mark reported for a separate, still-unconfirmed primary funding round, a gap worth watching for what it implies about near-term versus forward pricing.

3

Anduril has now had at least three distinct valuation marks discussed in 2026 -- $61 billion in its May Series H, and now this $90 billion tender alongside $100 billion primary talks.

4

A clean tender signals enough buyer demand among existing investors to absorb employee shares without needing new outside capital, a sign of continued confidence in defense tech despite a choppier IPO market elsewhere.

The VC Read

Value Add VC analysis

A $90B tender priced below the ~$100B figure floated for a new primary round is the real signal here -- it suggests existing investors are willing to buy employee stock at a discount to where they'd price fresh capital, which usually means demand is solid but not frothy enough to clear both tracks at the same mark. Diligence item: which specific investors are buying the tender shares, since that tells you whether this is insiders marking their own book or new capital setting the price.

Analysis

The Information reported Wednesday that Anduril Industries is in talks for an employee share sale that would value the defense-technology company at $90 billion, according to The Information. The outlet's reporting is paywalled beyond the headline, so the structure of the sale -- who is buying, and how many shares are involved -- has not been detailed publicly. Pulse has covered Anduril's rapid valuation climb extensively this year.

## A separate track from the reported $100 billion primary talks The tender comes as Anduril has separately been reported to be discussing a new primary funding round at roughly $100 billion, a figure that would mark another sharp step up from its last confirmed round. Anduril is reported to have closed a $5 billion Series H in May 2026 co-led by Thrive Capital and Andreessen Horowitz at a $61 billion valuation -- meaning the company has had multiple valuation marks floated within roughly five months: the reported $61 billion in May, this $90 billion tender, and talks near $100 billion for fresh primary capital.

An employee tender pricing below where a primary round is being discussed isn't unusual -- insiders and existing investors often negotiate tender pricing at a discount to where a new lead investor might set the next round, since a tender doesn't bring the signaling value or new capital a primary round does. But the gap is worth watching: a $10 billion spread between the two tracks suggests buyers are being disciplined even as they keep marking the company up.

“But the gap is worth watching: a $10 billion spread between the two tracks suggests buyers are being disciplined even as they keep marking the company up.”

Anduril, founded in 2017 and built around autonomous weapons systems, drones and its Lattice software for battlefield data, competes for Pentagon contracts against both venture-backed rivals like Shield AI and Saronic and legacy primes like Lockheed Martin and RTX. Palantir is the closest comparison on valuation trajectory -- a software-and-defense company that went from startup to public-market darling largely on the same thesis that Anduril is now being priced against: that software-defined defense systems can out-compete traditional hardware-heavy contractors on speed and cost.

What the valuation run misses is that none of this -- the May Series H, the reported tender, or the primary talks -- has translated into a public listing or an independent audited valuation. Every mark so far has come from private negotiations between Anduril and investors who already have a stake in seeing the number go up. That doesn't make the numbers wrong, but it does mean they haven't been tested by a market that could push back.

The next real test is whether the $90 billion tender closes at that price or gets repriced once buyers see terms for a new primary round -- and whether that primary round, if it happens, lands at $90 billion, the reported $100 billion, or somewhere in between.

ShareXLinkedInEmail

Key Sources

2 sources

THE WIRE in your inbox— Tech, startup & VC news with The VC Read, a few times a week. Free to subscribe, no spam.

No spam, unsubscribe anytime. Sent via Substack · Privacy · or subscribe on Substack ↗